Corestreet Logo

Crispr Therapeutics AG (CRSP) Insider Trading

Total insider buys:
  • $27,833,805.86
Total insider sells:
  • $316,118,036.43
Most recent insider trade:
  • Dec. 2, 2024
Most active insider trader:
  • Samarth Kulkarni
Trader NameDateTitleAmountPriceTypeTotal Value
Dec. 2, 2024CEO15,000$55.10Sell$826,500.00
Nov. 11, 2024CEO30,000$55.62Sell$1,668,600.00
Oct. 14, 2024CEO4,293$46.28Sell$198,680.04
Oct. 14, 2024General Counsel1,089$46.28Sell$50,398.92
June 21, 2024COO3,366$56.09Sell$188,798.94
April 15, 2024CEO19,582$59.91Sell$1,173,157.62
March 15, 2024CFO3,524$72.69Sell$256,159.56
March 15, 2024CEO20,000$72.48Sell$1,449,600.00
March 11, 2024General Counsel2,801$78.26Sell$219,206.26
March 11, 2024CEO9,802$78.26Sell$767,104.52
Feb. 20, 2024General Counsel1,913$79.67Sell$152,408.71
Feb. 20, 2024CEO6,370$79.67Sell$507,497.90
Feb. 15, 2024CEO20,000$80.36Sell$1,607,200.00
Jan. 29, 2024CEO50,000$60.51Sell$3,025,500.00
Jan. 16, 2024CEO20,000$62.50Sell$1,250,000.00
May 30, 2023CEO25,000$64.88Sell$1,622,000.00
April 25, 2023CEO25,000$50.67Sell$1,266,750.00
March 29, 2023CEO25,000$44.46Sell$1,111,500.00
Feb. 27, 2023CEO25,000$48.25Sell$1,206,250.00
Jan. 27, 2023CEO25,000$51.47Sell$1,286,750.00
Dec. 28, 2022CEO25,000$40.93Sell$1,023,250.00
Nov. 28, 2022CEO25,000$54.03Sell$1,350,750.00
Oct. 26, 2022CEO25,000$54.81Sell$1,370,250.00
Sept. 28, 2022CEO25,000$64.61Sell$1,615,250.00
Aug. 29, 2022CEO25,000$66.84Sell$1,671,000.00
July 27, 2022CEO25,000$75.91Sell$1,897,750.00
June 29, 2022CEO25,000$61.59Sell$1,539,750.00
Aug. 6, 2021CFO25,000$138.52Sell$3,463,000.00
Aug. 4, 2021CEO1,500$125.02Sell$187,530.00
July 19, 2021Director10,000$126.43Sell$1,264,300.00
June 30, 2021President25,000$165.00Sell$4,125,000.00
June 28, 2021Director20,375$152.48Sell$3,106,780.00
June 21, 2021President25,000$128.62Sell$3,215,500.00
June 15, 2021CEO30,000$126.43Sell$3,792,900.00
June 11, 2021Director10,000$126.61Sell$1,266,100.00
March 22, 2021Director30,374$132.37Sell$4,020,606.38
Jan. 19, 2021General Counsel27,500$204.94Sell$5,635,850.00
Jan. 15, 2021COO25,000$215.20Sell$5,380,000.00
Jan. 15, 2021CEO20,000$213.67Sell$4,273,400.00
Dec. 21, 2020VP23,551$149.23Sell$3,514,515.73
Dec. 16, 2020Director7,648$148.95Sell$1,139,169.60
Dec. 10, 2020CEO20,000$142.29Sell$2,845,800.00
Dec. 10, 2020Director33,000$143.35Sell$4,730,550.00
Dec. 7, 2020Director171,004$154.53Sell$26,425,248.12
Nov. 30, 2020President100,000$125.00Sell$12,500,000.00
Sept. 18, 2020Director3,035$86.87Sell$263,650.45
Sept. 16, 2020Director8,965$86.98Sell$779,775.70
Sept. 14, 2020Director1,155$84.89Sell$98,047.95
Sept. 10, 2020Director22,845$85.36Sell$1,950,049.20
Sept. 1, 2020President25,000$92.62Sell$2,315,500.00
First«1 of 4»Last

  • Insiders are both buying and selling Crispr Therapeutics AG stock.

  • The insider traders at Crispr Therapeutics AG are: Samarth Kulkarni, Rodger Novak, Kurt Von Emster, Bradley J Phd Bolzon, Corp /De/ Celgene, Tyler Dylan-Hyde, Pablo J Cagnoni, Thomas Woiwode, Lawrence Otto Klein, Vertex Pharmaceuticals (Europe, James R Kasinger, Michael John Tomsicek, Julianne Bruno, Simeon George, James R. Kasinger, Tony W Ho, Tony W. Ho, Bradley J. Phd Bolzon, Versant Venture Capital V, L.P, Raju Prasad, and Aktiengesellschaft Bayer

  • The most active insider trader at Crispr Therapeutics AG is Samarth Kulkarni with 34 trades.

  • Kurt Von Emster has sold the most Crispr Therapeutics AG stock with a total value of $68,130,025.01.

  • Aktiengesellschaft Bayer has bought the most Crispr Therapeutics AG stock with a total value of $23,999,976.00.

  • The most recent insider trade for Crispr Therapeutics AG was on Dec. 2, 2024.

  • The single biggest insider buy for Crispr Therapeutics AG was from Aktiengesellschaft Bayer with a total value of $11,999,988.00 on Jan. 5, 2018.

  • The single biggest insider sell for Crispr Therapeutics AG was from Kurt Von Emster with a total value of $35,353,500.00 on May 14, 2018.